27755550|t|The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
27755550|a|INTRODUCTION: Genome-Wide Association Studies have identified associations between lung function measures and Chronic Obstructive Pulmonary Disease (COPD) and chromosome region 6p21 containing the gene for the Advanced Glycation End Product Receptor (AGER, encoding RAGE). We aimed to (i) characterise RAGE expression in the lung, (ii) identify AGER transcripts, (iii) ascertain if SNP rs2070600 (Gly82Ser C/T) is associated with lung function and serum sRAGE levels and (iv) identify whether the Gly82Ser variant is functionally important in altering sRAGE levels in an airway epithelial cell model. METHODS: Immunohistochemistry was used to identify RAGE protein expression in 26 human tissues and qPCR was used to quantify AGER mRNA in lung cells. Gene expression array data was used to identify AGER expression during lung development in 38 fetal lung samples. RNA-Seq was used to identify AGER transcripts in lung cells. sRAGE levels were assessed in cells and patient serum by ELISA. BEAS2B-R1 cells were transfected to overexpress RAGE protein with either the Gly82 or Ser82 variant and sRAGE levels identified. RESULTS: Immunohistochemical assessment of 6 adult lung samples identified high RAGE expression in the alveoli of healthy adults and individuals with COPD. AGER/RAGE expression increased across developmental stages in human fetal lung at both the mRNA (38 samples) and protein levels (20 samples). Extensive AGER splicing was identified. The rs2070600T (Ser82) allele is associated with higher FEV1, FEV1/FVC and lower serum sRAGE levels in UK smokers. Using an airway epithelium model overexpressing the Gly82 or Ser82 variants we found that HMGB1 activation of the RAGE-Ser82 receptor results in lower sRAGE production. CONCLUSIONS: This study provides new information regarding the expression profile and potential role of RAGE in the human lung and shows a functional role of the Gly82Ser variant. These findings advance our understanding of the potential mechanisms underlying COPD particularly for carriers of this AGER polymorphism.
27755550	4	9	Ser82	ProteinMutation	tmVar:p|Allele|S|82;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	10	14	RAGE	Gene	177
27755550	55	59	RAGE	Gene	177
27755550	212	249	Chronic Obstructive Pulmonary Disease	Disease	MESH:D029424
27755550	251	255	COPD	Disease	MESH:D029424
27755550	279	283	6p21	Chromosome	6
27755550	353	357	AGER	Gene	177
27755550	368	372	RAGE	Gene	177
27755550	404	408	RAGE	Gene	177
27755550	447	451	AGER	Gene	177
27755550	488	497	rs2070600	SNP	tmVar:rs2070600;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	499	511	Gly82Ser C/T	ProteinMutation	tmVar:p|SUB|G|82|S,T;HGVS:p.G82S,T;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	599	607	Gly82Ser	ProteinMutation	tmVar:p|SUB|G|82|S;HGVS:p.G82S;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606;CA#:3738264
27755550	754	758	RAGE	Gene	177
27755550	784	789	human	Species	9606
27755550	828	832	AGER	Gene	177
27755550	901	905	AGER	Gene	177
27755550	996	1000	AGER	Gene	177
27755550	1068	1075	patient	Species	9606
27755550	1092	1101	BEAS2B-R1	CellLine	CVCL:UR57
27755550	1140	1144	RAGE	Gene	177
27755550	1169	1174	Gly82	ProteinMutation	tmVar:p|Allele|G|82;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	1178	1183	Ser82	ProteinMutation	tmVar:p|Allele|S|82;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	1301	1305	RAGE	Gene	177
27755550	1371	1375	COPD	Disease	MESH:D029424
27755550	1377	1381	AGER	Gene	177
27755550	1382	1386	RAGE	Gene	177
27755550	1439	1444	human	Species	9606
27755550	1529	1533	AGER	Gene	177
27755550	1563	1572	rs2070600	SNP	tmVar:rs2070600;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	1575	1580	Ser82	ProteinMutation	tmVar:p|Allele|S|82;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	1726	1731	Gly82	ProteinMutation	tmVar:p|Allele|G|82;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	1735	1740	Ser82	ProteinMutation	tmVar:p|Allele|S|82;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	1764	1769	HMGB1	Gene	3146
27755550	1788	1792	RAGE	Gene	177
27755550	1793	1798	Ser82	ProteinMutation	tmVar:p|Allele|S|82;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606
27755550	1947	1951	RAGE	Gene	177
27755550	1959	1964	human	Species	9606
27755550	2005	2013	Gly82Ser	ProteinMutation	tmVar:p|SUB|G|82|S;HGVS:p.G82S;VariantGroup:0;CorrespondingGene:177;RS#:2070600;CorrespondingSpecies:9606;CA#:3738264
27755550	2103	2107	COPD	Disease	MESH:D029424
27755550	2142	2146	AGER	Gene	177
27755550	Positive_Correlation	MESH:D029424	RS#:2070600;HGVS:p.G82S;CorrespondingGene:177
27755550	Association	MESH:D029424	177
27755550	Association	MESH:D029424	177

